- 全部删除
您的购物车当前为空
Trifluoperazine dihydrochloride (SKF5019) 是一种抗精神病药物,靶向中枢多巴胺受体。它是流感病毒形态发生的可逆抑制剂,是NUPR1抑制剂,具有抗癌活性。它是钙调蛋白抑制剂,还可抑制 P-糖蛋白,可研究精神分裂症。

Trifluoperazine dihydrochloride (SKF5019) 是一种抗精神病药物,靶向中枢多巴胺受体。它是流感病毒形态发生的可逆抑制剂,是NUPR1抑制剂,具有抗癌活性。它是钙调蛋白抑制剂,还可抑制 P-糖蛋白,可研究精神分裂症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 132 | In stock | |
| 50 mg | ¥ 179 | In stock | |
| 100 mg | ¥ 247 | In stock | |
| 500 mg | ¥ 579 | In stock | |
| 1 g | ¥ 849 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 150 | In stock |
Trifluoperazine dihydrochloride 相关产品
| 产品描述 | Trifluoperazine dihydrochloride (SKF5019) is a potent dopamine D2 receptor inhibitor used as an antipsychotic and an antiemetic. |
| 靶点活性 | D2 receptor:1.1 nM |
| 体外活性 | Trifluoperazine 对α1A-与α1B-肾上腺素受体上的结合Ki值分别为27.6 nM和19.2 nM,其α1B/α1A比例为0.7。[2] Trifluoperazine 抑制结核分枝杆菌(Mtb)的MICs为7.6 μg/mL。[3] 低于14.78 mM的Trifluoperazine 能剂量依赖性抑制小鼠脾NK细胞的细胞毒性及效应细胞与靶细胞结合。Trifluoperazine 还能抑制干扰素-alpha或白细胞介素-2诱导的NK细胞细胞杀伤活性的增强。[4] Trifluoperazine 抑制人脑电压依赖性钾通道Kv2.1的基因表达(hKv2.1)。[5] |
| 体内活性 | Trifluoperazine以剂量依赖的方式降低大鼠在离散试验回避任务下的避免反应,并增加了反应失败的次数。[6] |
| 别名 | 盐酸三氟拉嗪, Urinox, Trifluoperazine 2HCl, SKF5019 |
| 分子量 | 480.43 |
| 分子式 | C21H26Cl2F3N3S |
| CAS No. | 440-17-5 |
| Smiles | Cl.CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1 |
| 密度 | no data available |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: 88 mg/mL (183.17 mM), Sonication is recommended. DMSO: 82 mg/mL (170.68 mM), Sonication is recommended. Ethanol: 89 mg/mL (185.25 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO/H2O/Ethanol
| ||||||||||||||||||||||||||||||||||||
评论内容